Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 seasonMarc Rondy, Alain Moren, Alin Gherasim et al.|Eurosurveillance|2017Cited by 35
Vaccine effectiveness against influenza A(H3N2) and B among laboratory‐confirmed, hospitalised older adults, Europe, 2017‐18: A season of B lineage mismatched to the trivalent vaccineAngela Rose, Marta Valenciano, Esther Kissling et al.|Influenza and Other Respiratory Viruses|2020Cited by 21
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021Angela Rose, Regina Demlová, Nathalie Nicolay et al.|Eurosurveillance|2023Cited by 4
Enhanced surveillance of hospitalized COVID-19 patients in Europe: an evaluation of the I-MOVE-COVID-19 surveillance networkJohanna Young, Philippe Vanhems, Monika Kuliešė et al.|European Journal of Public Health|2023Cited by 2
Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccineAngela Rose, Marta Valenciano, Esther Kissling et al.|LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)|2020Cited by 0